Skip to content

Study of Visual-spatial Attention by Eye Tracking as a Function of Central or Peripheral Visual Impairment

Study of Visual-spatial Attention by Oculomotor Recording (Eye Tracking) as a Function of Central or Peripheral Visual Impairment

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03505398
Acronym
BEHAVE
Enrollment
71
Registered
2018-04-23
Start date
2018-05-15
Completion date
2023-06-20
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central or Peripheral Visual Impairment

Brief summary

The objective of this pilot work is to determine the role of central and peripheral visions in explicit attention processes (saccade planning) in the case of visual impairment.

Interventions

define the retinal fixation point and the differential sensitivity threshold of the retina.

PROCEDUREvisual acuity

using ETDRS scales

recording visual attention based on central or peripheral visual information

PROCEDUREeye movements recording

recording of explicit visual attention based on central or peripheral visual information

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female ≥18 years; * Patient with a central visual deficit (central scotoma on the visual field: DMLA, cones dystrophy ...) or peripheral (annular scotoma: chronic glaucoma, retinitis pigmentosa ...) or without visual deficit (corrected visual acuity and visual field) * Patient agreeing to participate in the study and signing informed consent * Patient affiliated to social security

Exclusion criteria

* Pregnant woman * Patient with known epilepsy * Major under judicial safeguard, or deprived of liberty * Major under guardianship or curatorship or admitted to a health or social institution for purposes other than research.

Design outcomes

Primary

MeasureTime frame
recording of eye movements (central versus peripheral)Day 0
Measurement of visual acuity (central versus peripheral)Day 0
Microperimetry recording (central versus peripheral)Day 0
recording of automated visual field (central versus peripheral)Day 0

Secondary

MeasureTime frame
Measurement of visual acuity (patient versus control)Day 0
Microperimetry recording (patient versus control)Day 0
recording of automated visual field (patient versus control)Day 0
recording of eye movements (patient versus control)Day 0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026